Centre de recherche de l’Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval, Québec, QC, Canada
Department of Medicine, Faculty of Medicine, Université Laval, Québec, QC, Canada
Dr. Benoit Arsenault obtained his Ph.D. in Physiology-Endocrinology from Université Laval in Québec City, Canada in 2009. After two postdoctoral fellowships at the Academic Medical Center in Amsterdam and at the Montreal Heart Institute, Dr. Arsenault joined the Department of Medicine of Université Laval in 2013. He is also a research scientist in the cardiology axis at the Québec Heart and Lung Institute.
Dr. Arsenault’s team use genetic tools such as Mendelian randomization and family studies to investigate the causes and consequences of cardiometabolic diseases such as non-alcoholic fatty liver disease, dyslipidemia, type 2 diabetes and cardiovascular diseases. He also leads a research program funded by the Canadian Institutes of Health Research on the basic and genetic mechanisms through which Lipoprotein(a) contributes to heart valve disorders such as calcific aortic valve stenosis using multi-omic technologies.
Dr. Arsenault holds a junior scholar award from the Fonds de recherche du Québec: Santé (FRQS) and his research is also funded by the Foundation of the Québec Heart and Lung Institute.
Dr. Arsenault is a member of the International Chair on Cardiometabolic Risk (ICCR), the Lipoprotein(a) Foundation Scientific Advisory Board and the Genomic Investigation of Statin Therapy (GIST) and the GENIUS-CHD consortia. He has authored or co-authored more than 130 peer-reviewed manuscripts. He is also on the Editorial board and serves as social media curator for American Journal of Physiology – Endocrinology and Metabolism.
Areas of Interest
- Cardiometabolic diseases
- Cardiovascular diseases
- Calcific aortic valve stenosis
- Abdominal obesity
- Healthy aging